Ask the Expert

First-Line Treatment of Advanced Biliary Tract Cancers (BTCs)

Ask the Expert — April 10, 2024

Use of first-line (1L) IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin (gem-cis) chemotherapy in patients with locally advanced or metastatic biliary tract cancers

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

CCA News Print Edition

CCA News Weekly e‑Newsletter

I have reviewed and consent to the terms of CCA News's Privacy Policy, and CCA News has my permission to retain my information in its database, and to forward pertinent communications to me.

Ask the Expert

Subscribe Today!

I'd like to receive:

Stay In The Know